Eyenovia Stock Alpha and Beta Analysis
| EYEN Stock | USD 0.09 0.02 15.55% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eyenovia. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eyenovia over a specified time horizon. Remember, high Eyenovia's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eyenovia's market risk premium analysis include:
Beta 3.04 | Alpha (1.97) | Risk 12.2 | Sharpe Ratio (0.13) | Expected Return (1.61) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Eyenovia |
Eyenovia Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eyenovia market risk premium is the additional return an investor will receive from holding Eyenovia long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eyenovia. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eyenovia's performance over market.| α | -1.97 | β | 3.04 |
Eyenovia expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Eyenovia's Buy-and-hold return. Our buy-and-hold chart shows how Eyenovia performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Eyenovia Market Price Analysis
Market price analysis indicators help investors to evaluate how Eyenovia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eyenovia shares will generate the highest return on investment. By understating and applying Eyenovia stock market price indicators, traders can identify Eyenovia position entry and exit signals to maximize returns.
Eyenovia Return and Market Media
The median price of Eyenovia for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.5 with a coefficient of variation of 32.17. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 0.45, and mean deviation of 0.1. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Strahlman Ellen R of 6744 shares of Eyenovia at 1.6018 subject to Rule 16b-3 | 09/06/2024 |
2 | Insider Trading | 09/25/2024 |
3 | Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05 percent for Post-Operative Inflammation and Pain Follo... | 09/26/2024 |
4 | Eyenovia Announces Share Offering and Warrant Sale for Growth - TipRanks | 09/30/2024 |
5 | Eyenovia Inc Q2 2024 Earnings Call Highlights Strategic Advances Amid Financial Challenges | 10/09/2024 |
6 | Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at theAmerican Academy of Ophthalmology 2024 Expo | 10/16/2024 |
7 | Acquisition by Andrew Jones of 200000 shares of Eyenovia at 0.5501 subject to Rule 16b-3 | 11/06/2024 |
8 | Eyenovia GAAP EPS of -0.11 in-line, revenue of 1.62M beats by 1.51M | 11/12/2024 |
9 | Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline | 11/15/2024 |
10 | Eyenovia Provides Update on Restructuring Efforts | 11/22/2024 |
11 | Eyenovia, Inc. Announces Pricing of 1.3 Million Registered Direct Offering | 11/25/2024 |
About Eyenovia Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eyenovia or other stocks. Alpha measures the amount that position in Eyenovia has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 56.02 | 60.2K | 54.2K | 56.9K | PTB Ratio | 5.14 | 3.18 | 9.48 | 15.46 |
Eyenovia Upcoming Company Events
As portrayed in its financial statements, the presentation of Eyenovia's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eyenovia's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Eyenovia's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Eyenovia. Please utilize our Beneish M Score to check the likelihood of Eyenovia's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Eyenovia
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Eyenovia Backtesting, Eyenovia Valuation, Eyenovia Correlation, Eyenovia Hype Analysis, Eyenovia Volatility, Eyenovia History and analyze Eyenovia Performance. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Eyenovia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.